Sygnature Discovery’s Post

Sygnature Discovery will be attending the 39th ACS National Medicinal Chemistry Symposium (NMCS 2026), a biennial meeting that brings together industry and academic chemists to examine how these challenges are being addressed in practice, from small molecule therapeutics to targeted protein degradation and covalent inhibitors. We’ll be there to share perspectives shaped by hands on medicinal chemistry and integrated discovery work, with an emphasis on feasibility, risk, and making sound choices early in a program. 👥 Meet Allan Jordan (アラン ジョーダン), Ridwan Islam, M. Pharm., Ph.D., and Stuart Onions at Booth #20. Allan and Stuart will be presenting posters: – Direct to Discovery: Extending Direct to Biology paradigms to accelerate drug discovery (Allan Jordan) – Discovery of Opelconazole (Stuart Onions) ✨ We’re also hosting a private event on June 1st at 7pm EDT - visit our booth or click the link in the comments to secure your free invite (limited capacity). Join the conversation. #Pharma #DrugDiscovery #Biotech #CRO